CTC
Dashboard
Interface
Vaccinations
Add Vaccination
All Vaccinations
Packages
Add Package
All Packages
Blogs
Add Blog
All Blogs
Section Content
Add Section Item
All Section Items
Contacts
All Contacts
Settings
Home Page Settings
Contact Us Settings
About Page Settings
Profile Settings
Pages
Add Page
All Pages
3+
Alerts Center
December 12, 2019
A new monthly report is ready to download!
December 7, 2019
$290.29 has been deposited into your account!
December 2, 2019
Spending Alert: We've noticed unusually high spending for your account.
Show All Alerts
7
Message Center
Hi there! I am wondering if you can help me with a problem I've been having.
Emily Fowler · 58m
I have the photos that you ordered last month, how would you like them sent to you?
Jae Chun · 1d
Last month's report looks great, I am very happy with the progress so far, keep up the good work!
Morgan Alvarez · 2d
Am I a good boy? The reason I ask is because someone told me that people say this to all dogs, even if they aren't good...
Chicken the Dog · 2w
Read More Messages
Admin
Profile
Settings
Activity Log
Logout
Edit Vaccination
Name
Description
The HPV vaccine (Gardasil 9) protects against human papillomavirus, which can cause cervical, anal, head and neck cancers, and genital warts. Recommended by UK JCVI as part of the NHS school programme and available privately for eligible adults up to age 45.
Price
Currency
Dose
Age From
Age To
Vaccination Link
Additional Details
Timing
Effectiveness
Duration
Additional Notes
Timing Note
Under-15s typically need 2 doses; those aged 15–45 usually require 3 doses. HPV vaccination is not linked to travel but is a key preventive vaccine.
Effectiveness Note
The HPV vaccine has an efficacy rate of more than 90% in preventing infections from high, risk HPV types. It is estimated to prevent 70% of cervical cancer cases and almost all cases of genital warts from HPV. There is evidence that the vaccinated population has seen fewer HPV infections and lesions than the unvaccinated population. The efficacy of the HPV vaccine has been proven to last for a minimum of 10-15 years without any sign of suppressed immunity.
Duration Note
To be HIV-positive at the time of vaccination before their 25th birthday or 45th birthday
Risk Information
High Risk Areas (one per line)
HPV infection is common worldwide Higher cervical cancer incidence in low- and middle-income countries with limited screening
Traveller Risk Factors (one per line)
Adolescents and young adults (pre-sexual debut ideal) Adults up to age 45 not previously vaccinated Men who have sex with men Immunocompromised individuals
Protection Information
Protection Title
Protection Description
The HPV vaccine can train the body’s immune system to resist certain types of HPVs before they cause infection. This will prevent people from being infected for an extended period, which can lead to cancer. When most people within the society are vaccinated, it prevents the spread of HPV within communities.
Media
Image
Drag & drop an image here or click to select
Update
Back
Ready to Leave?
×
Select "Logout" below if you are ready to end your current session.
